Ra Capital Management as of June 30, 2017
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 22 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 17.8 | $155M | 5.6M | 27.76 | |
| Wave Life Sciences (WVE) | 15.1 | $132M | 7.1M | 18.60 | |
| Avexis | 12.3 | $108M | 1.3M | 82.16 | |
| Achillion Pharmaceuticals | 7.2 | $63M | 14M | 4.59 | |
| Biohaven Pharmaceutical Holding | 7.0 | $61M | 2.4M | 25.00 | |
| G1 Therapeutics (GTHX) | 5.4 | $47M | 2.7M | 17.44 | |
| Ignyta | 4.8 | $42M | 4.0M | 10.35 | |
| Esperion Therapeutics (ESPR) | 3.9 | $34M | 732k | 46.28 | |
| Myovant Sciences | 3.8 | $33M | 2.8M | 11.70 | |
| BioCryst Pharmaceuticals (BCRX) | 3.3 | $29M | 5.2M | 5.56 | |
| Ra Pharmaceuticals | 2.9 | $25M | 1.4M | 18.74 | |
| Radius Health | 2.6 | $23M | 497k | 45.23 | |
| Zogenix | 2.5 | $21M | 1.5M | 14.50 | |
| Aquinox Pharmaceuticals | 2.2 | $20M | 1.4M | 14.07 | |
| AVEO Pharmaceuticals | 2.1 | $19M | 8.4M | 2.22 | |
| Acorda Therapeutics | 2.0 | $18M | 900k | 19.70 | |
| Akebia Therapeutics (AKBA) | 1.4 | $12M | 836k | 14.37 | |
| Sangamo Biosciences (SGMO) | 1.3 | $11M | 1.3M | 8.80 | |
| Dicerna Pharmaceuticals | 0.9 | $7.7M | 2.4M | 3.17 | |
| Tg Therapeutics (TGTX) | 0.8 | $7.0M | 700k | 10.05 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $4.4M | 591k | 7.36 | |
| Proteon Therapeutics | 0.2 | $2.0M | 1.3M | 1.53 |
